Salvia Jain
ScholarGPS® ID: 16929233018308
Affiliation History
Field
Medicine
Discipline
Hematology
Top Specialties
Lymphoma | T-cell Lymphoma | Multiple Myeloma
Metrics Summary
Publication Count
28
Predicted Citations
565
Predicted h-index
12
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Leukemia & Lymphoma, volume 65, issue 6, pages 736-745 (2024). |
Blood, volume 142, issue Supplement 1, pages 4856-4856 (2023). |
Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma (journal article) Blood Advances, volume 7, issue 14, pages 3760-3763 (2023). |
Blood, volume 140, issue Supplement 1, pages 9422-9424 (2022). |
Blood, volume 140, issue Supplement 1, pages 9425-9426 (2022). |
Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis (journal article) Blood Advances, volume 6, issue 16, pages 4740-4762 (2022). |
Novel Single Agents Are Equivalent to Conventional Chemotherapy Inpatients with Relapsed and Refractory Mature T-Cell Lymphomas: A Meta-Analysis (journal article) Blood, volume 138, issue Supplement 1, pages 1431-1431 (2021). |
Hepatosplenic T‐cell Lymphomas (book chapter) In The Peripheral T‐Cell Lymphomas Wiley (2021) |
Targeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas (journal article) Blood, volume 134, issue 17, pages 1430-1440 (2019). |
American Journal of Hematology, volume 94, issue 6, pages 641-649 (2019). |
Role of Single Agent and Combination Chemotherapy Strategies in Relapsed/Refractory Peripheral T-Cell Lymphoma: Results from the Complete Registry (journal article) Blood, volume 132, issue Supplement 1, pages 2926-2926 (2018). |
Blood, volume 132, issue Supplement 1, pages 2728-2728 (2018). |
Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma (journal article) Molecular Cancer Therapeutics, volume 16, issue 10, pages 2304-2314 (2017). |
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC 1 (journal article) British Journal of Haematology, volume 176, issue 6, pages 929-938 (2017). |
DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma (journal article) Journal of Immunotherapy, volume 40, issue 9, pages 315-322 (2017). |
Blood, volume 126, issue 23, pages 4218-4218 (2015). |
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma (journal article) Blood, volume 126, issue 3, pages 354-362 (2015). |
Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma (journal article) Clinical Cancer Research, volume 21, issue 9, pages 2096-2106 (2015). |
Bone Marrow Stroma Protects Myeloma Cells from Cytotoxic Damage Via Induction of the Oncoprotein MUC1 (journal article) Blood, volume 124, issue 21, pages 3378-3378 (2014). |
Myeloid-Derived Suppressor Cells Are Expanded in Patients with AML and Are Dependent on MUC1 Expression (journal article) Blood, volume 124, issue 21, pages 226-226 (2014). |